SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-016674
Filing Date
2013-03-01
Accepted
2013-03-01 13:50:09
Documents
3
Period of Report
2013-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-6343_18k.htm 8-K 27902
2 EX-99.1 a13-6343_1ex99d1.htm EX-99.1 23927
3 GRAPHIC g63431mmi001.jpg GRAPHIC 5045
  Complete submission text file 0001104659-13-016674.txt   60177
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13656247
SIC: 2836 Biological Products, (No Diagnostic Substances)